Three grants issued by the California Institute of Regenerative Medicine have been terminated, reports The Scientist. In reviewing the recipients' first year progress reports, CIRM identified underperforming project. The reviewers then contacted the PIs to learn what the difficulties were and then if the grantees' follow-up report didn't show improvement, the grant was terminated. "Termination is a last option," CIRM's Don Gibbons says.